Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cure Pharmaceutical Holding Corp (CURR)

Cure Pharmaceutical Holding Corp (CURR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 103,339
  • Shares Outstanding, K 44,930
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 2.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8100 +17.46%
on 05/22/20
2.6500 -19.77%
on 05/14/20
-0.0440 (-2.03%)
since 04/24/20
3-Month
1.2500 +70.08%
on 03/18/20
2.6500 -19.77%
on 05/14/20
+0.0260 (+1.24%)
since 02/26/20
52-Week
1.2500 +70.08%
on 03/18/20
5.8300 -63.53%
on 07/12/19
-1.7740 (-45.49%)
since 05/24/19

Most Recent Stories

More News
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion...

CURR : 2.1260 (-7.57%)
CURE Pharmaceutical [OTCQB:CURR] Secures Chinese Patent on its Oral Thin Films to Treat Erectile Dysfunction

CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers the loading of high amounts...

CURR : 2.1260 (-7.57%)
CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier provider...

CURR : 2.1260 (-7.57%)
UPDATE - CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

In a release issued earlier today by CURE Pharmaceutical (OTC: CURR), the company is updating this release to include forward looking statements.

CURR : 2.1260 (-7.57%)
CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe's leading pharmaceutical...

CURR : 2.1260 (-7.57%)
Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

Oakville, Ontario--(Newsfile Corp. - December 18, 2019) - ())(""or the""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart...

CURR : 2.1260 (-7.57%)
CRDL.TO : 2.53 (+1.20%)
CRTPF : 1.7985 (-1.18%)
CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD Micro Main Event on Wednesday, December 11 at 9:45...

CURR : 2.1260 (-7.57%)
CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers' Chairman, John K. Bell, To Board of Directors

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40...

CURR : 2.1260 (-7.57%)
CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension

CURE Pharmaceutical (OTC: CURR) ("CURE"), an innovative drug delivery and development company, today announced that it purchased a $200,000 convertible promissory note issued by Coeptis Pharmaceuticals,...

CURR : 2.1260 (-7.57%)
CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line creating CUREform(TM) which includes CUREfilm, one of...

CURR : 2.1260 (-7.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CURR with:

Key Turning Points

2nd Resistance Point 2.3953
1st Resistance Point 2.2607
Last Price 2.1260
1st Support Level 2.0307
2nd Support Level 1.9353

See More

52-Week High 5.8300
Fibonacci 61.8% 4.0804
Fibonacci 50% 3.5400
Fibonacci 38.2% 2.9996
Last Price 2.1260
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar